Rev Genomics
Rev Genomics, based in Oakland, California, specializes in advanced genomic technologies for breeding high-value crops, featuring innovations like whole genome selection and tissue culture.
Company Overview
Rev Genomics is a healthcare diagnostics company based in Oakland, CA. Specializing in high-value crops, the company leverages advanced tools like whole genome selection, tissue culture, molecular genetics, and in-house metabolite analytics to create new cultivars. Their innovative technology is designed for breeders, cultivators, and seed banks seeking disruptive genomic solutions.
Y-Combinator Affiliation
Rev Genomics is a participant of Y-Combinator's S17 batch. Y-Combinator is known for backing startups with high growth potential, and this affiliation has contributed to the company's reputation in the healthcare diagnostics sector. Their involvement in Y-Combinator has helped them gain valuable industry insights and network connections.
Innovative Technologies and Offerings
Rev Genomics uses pioneering tissue culture techniques to develop true-breeding cultivars with unique and stable phenotypes. By employing whole genome selection, they can breed and select for multiple traits simultaneously. Their genomic technology shortens traditional pheno-hunting timelines, making the process faster and more efficient. They provide molecular fingerprints for unique strains and seeds through collaborations with industry partners.
Market and Commercialization
Rev Genomics has successfully created new high-value crop cultivars that are currently being commercialized in California. The company's platform and technological advancements have been featured in TechCrunch, highlighting their impact in the industry. Their crop cultivars contain valuable biochemicals, offering a significant advantage in the market.
Contact Information
For inquiries regarding Rev Genomics' products and services, interested parties can reach out via email at sales@revgenomics.com or by phone at (510) 325-0484. The company actively engages with breeders, cultivators, and seed banks to offer their innovative genomic technology.